Publicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (21)

2021

  1. A novel circulating microRNA for the detection of acute myocarditis

    New England Journal of Medicine, Vol. 384, Núm. 21, pp. 2014-2027

  2. Beta-blocker therapy in elderly patients with renal dysfunction and heart failure

    Journal of Geriatric Cardiology, Vol. 18, Núm. 1, pp. 20-29

  3. Coexistence of transmural and lateral wavefront progression of myocardial infarction in the human heart

    Revista Espanola de Cardiologia, Vol. 74, Núm. 10, pp. 870-877

2019

  1. Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients

    Aging, Vol. 11, Núm. 9, pp. 2874-2888

  2. Neoadjuvant metformin added to systemic therapy decreases the proliferative capacity of residual breast cancer

    Journal of Clinical Medicine, Vol. 8, Núm. 12

  3. Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study

    Clinical Breast Cancer, Vol. 19, Núm. 2, pp. 105-112

  4. Point-of-care ultrasound: Is it time to include it in the paediatric specialist training program?

    Anales de Pediatria, Vol. 91, Núm. 3, pp. 206.e1-206.e13

  5. The C allele of ATM rs11212617 associates with higher pathological complete remission rate in breast cancer patients treated with neoadjuvant metformin

    Frontiers in Oncology, Vol. 9, Núm. MAR

2018

  1. A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: The METTEN study

    Oncotarget, Vol. 9, Núm. 86, pp. 35687-35704

2017

  1. Evolution of energy related metabolites in plasma from newborns with hypoxic-ischemic encephalopathy during hypothermia treatment

    Scientific Reports, Vol. 7, Núm. 1

  2. Impacto del territorio miocárdico infartado en la cuantificación del área en riesgo mediante cardiorresonancia magnética

    Revista Espanola de Cardiologia, Vol. 70, Núm. 5, pp. 323-330

  3. Neutrophil stunning by metoprolol reduces infarct size

    Nature Communications, Vol. 8

2016

  1. Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension

    Basic Research in Cardiology, Vol. 111, Núm. 4

  2. Impact of the Timing of Metoprolol Administration during STEMI on Infarct Size and Ventricular Function

    Journal of the American College of Cardiology, Vol. 67, Núm. 18, pp. 2093-2104

2015

  1. Association of myocardial T1-mapping CMR with hemodynamics and RV performance in pulmonary hypertension

    JACC: Cardiovascular Imaging, Vol. 8, Núm. 1, pp. 76-82

  2. BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitors

    Melanoma Research, Vol. 25, Núm. 6, pp. 486-495

  3. Efficacy and safety of out-of-hospital intravenous metoprolol administration in anterior st-segment elevation acute myocardial infarction: Insights from the METOCARD-CNIC trial

    Annals of Emergency Medicine, Vol. 65, Núm. 3, pp. 318-324

  4. Impact of left ventricular hypertrophy on troponin release during acute myocardial infarction: New insights from a comprehensive translational study

    Journal of the American Heart Association, Vol. 4, Núm. 1

2014

  1. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: Results from the Metocard-CNIC trial (Effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction)

    Journal of the American College of Cardiology, Vol. 63, Núm. 22, pp. 2356-2362

  2. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes

    Basic Research in Cardiology, Vol. 109, Núm. 4